How is pulmonary artery end-diastolic pressure estimated using transthoracic echocardiography?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 28, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Estimating Pulmonary Artery End-Diastolic Pressure by Echocardiography

Pulmonary artery end-diastolic pressure (PAEDP) is estimated using continuous-wave Doppler by measuring the end-diastolic velocity of the pulmonary regurgitation jet and applying the modified Bernoulli equation: PAEDP = 4(end-diastolic PR velocity)² + estimated right atrial pressure.

Technical Methodology

The estimation requires identifying and measuring the pulmonary regurgitation (PR) signal using continuous-wave Doppler echocardiography. Specifically, you need to:

  • Position the transducer at the left sternal border to image the pulmonic valve and pulmonary artery
  • Obtain the pulmonary regurgitation signal using continuous-wave Doppler
  • Measure the end-diastolic velocity of the regurgitant jet (the velocity at end-diastole, just before the next systole)
  • Calculate the pressure gradient using the simplified Bernoulli equation: 4V²
  • Add estimated right atrial pressure (RAP) to obtain PAEDP

Estimating Right Atrial Pressure

RAP estimation is critical and should be based on inferior vena cava (IVC) assessment 1:

  • IVC diameter <2.1 cm with >50% collapse on sniff → RAP = 3 mmHg (range 0-5 mmHg)
  • IVC diameter >2.1 cm with <50% collapse on sniff or <20% on quiet inspiration → RAP = 15 mmHg (range 10-20 mmHg)
  • Intermediate scenarios → RAP = 8 mmHg (range 5-10 mmHg)

Clinical Validation and Accuracy

Research demonstrates strong correlation between Doppler-derived PAEDP and catheterization measurements. A study using simultaneous Doppler and catheterization showed excellent correlation (r = 0.935, SEE = 7.4 mmHg) 2. Another investigation found even stronger correlation when using the mean diastolic pressure gradient (r = 0.947, SEE = 5.1 mmHg) 2. More recent data confirmed good correlation between Doppler PAEDP and both catheter-measured PAEDP (r = 0.90, SEE = 3.3 mmHg) and pulmonary wedge pressure (r = 0.88, SEE = 3.7 mmHg) 3.

Important Clinical Caveats

The technique requires adequate pulmonary regurgitation to be present. If no PR signal is detectable, PAEDP cannot be estimated using this method. In such cases, you must rely on other echocardiographic signs of pulmonary hypertension 1.

The end-diastolic PR velocity specifically correlates with PAEDP and provides information about left ventricular filling pressures. An end-diastolic PR gradient >5.0 mmHg is associated with cardiac dysfunction and elevated filling pressures 4.

Integration with Comprehensive Assessment

While PAEDP estimation is valuable, the 2015 ESC/ERS guidelines emphasize that echocardiographic assessment of pulmonary hypertension should not rely on a single measurement 1. The comprehensive evaluation should include:

  • Tricuspid regurgitation velocity for systolic PA pressure
  • RV size and function (RV/LV basal diameter ratio, septal flattening)
  • PA diameter (>25 mm suggests PH)
  • RV outflow acceleration time (<105 msec suggests PH)
  • Early diastolic PR velocity (>2.2 m/s suggests elevated PAEDP)

The early diastolic PR velocity >2.2 m/s is specifically listed as one of the echocardiographic signs suggesting pulmonary hypertension in the guideline framework 1, 5.

Practical Limitations

Doppler-derived pressure estimations can be inaccurate in individual patients despite strong population correlations 1. When treatment decisions for pulmonary hypertension are being considered, echocardiography alone is insufficient—cardiac catheterization is required for definitive hemodynamic assessment 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.